Advocacy intelligence hub — real-time data for patient organizations
Changchun BCHT Biotechnology Co. — PHASE1
Institute of Medical Biology, Chinese Academy of Medical Sciences — PHASE1, PHASE2
CanSino Biologics Inc. — PHASE1
Canadian Immunization Research Network — PHASE4
Changchun BCHT Biotechnology Co. — PHASE3
GC Biopharma Corp — PHASE1, PHASE2
Universiti Putra Malaysia — NA
LG Chem — PHASE2, PHASE3
Institute of Medical Biology, Chinese Academy of Medical Sciences — PHASE4
Bandim Health Project — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Yuemei Hu, Bachelor
Jiangsu Provincial Center for Diseases Control and Prevention
General Manager
Tanabe Pharma Corporation
Sean O'Leary, MD, MPH
University of Colorado, Denver
Raman Rao
Shantha Biotechnics Limited, Hyderabad, India
Rigmor Thorstensson, Assoc. Prof.
Swedish Institute for Infectious Disease Control
Anne Fiquet
SPMSD